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decrease in the expression level of PS synthases, because the Abstract We have previously shown that a Chinese hamster 
ovary (CHO) cell mutant defective in phosphatidylserine serine base-exchange activity in an extract of cells grown with 
synthase I recovers the enzyme activity on transfection with a PS is not significantly different from that in an extract of cells 
pssA cDNA clone isolated from the parental CHO-K1. The grown without PS [9]. In addition, we isolated a CHO cell 
resultant transfectant, CDT-1, exhibited about 20-fold higher mutant in which PS synthesis is elevated about 2-fold and 
specific activity of the enzyme in the membrane fraction than remarkably resistant o inhibition by exogenous PS, as com- 
CHO-K1 cells. Polyclonal antibodies against two peptides of the pared with the parental cells [10]. These findings suggested the 
predicted pssA product cross-reacted with a membrane protein existence of a factor that modulates the activities of PS 
having an apparent molecular mass of 42 kDa, which was synthases in intact cells in response to the cellular PS level. 
overproduced in CDT-1 cells. By immunoprecipitation with the Cloned genes involved in PS metabolism can serve as a 
antibody, pbosphatidylserine synthase I activity as well as the 42- 
useful tool to understand the molecular mechanisms under- kDa protein was eliminated from solubilized membrane proteins 
of CDT-1 cells. Both the enzyme activity and the 42-kDa protein lying the biosynthesis and metabolic regulation of PS. By 
of CHO-K1 cells were enriched in the mitochondria-associated genetic complementation with a PS-auxotrophic CHO cell 
membrane fraction and the microsome fraction, but neither was mutant, PSA-3, which lacks PS synthase I activity, we isolated 
enriched in the mitocbondria fraction or the cytosol fraction, a pssA cDNA clone which transforms PSA-3 to a PS proto- 
These results suggest hat the pssA gene encodes phosphatidyl- troph, from CHO-K1 cells [11]. The transformant, CDT-1, 
serine synthase I. exhibits higher specific activity of PS synthase I than CHO- 
K1 cells. The pssA product deduced from the cDNA sequence 
Key words." Phosphatidylserine; Phosphatidylserine synthase; is an integral membrane protein of 471 amino acids with 
pssA; Phospholipid base-exchange r action; Mitochondria- several potential membrane-spanning domains. To clarify 
associated membrane; CHO cell the biochemical characteristics and the function of the pssA 
product, we have here generated antibodies against peptides 
of the predicted pssA product. Using the antibodies, we ob- 
1. Introduction tained several ines of evidence that the pssA product is PS 
synthase I. 
Phosphatidylserine (PS) is one of the major phospholipids 
in mammalian cell membranes, interacting with various pro- 2. Materials and methods 
teins, such as protein kinase C [1], MARCKS (myristoylated 
alanine-rich C kinase substrate) [2], coagulation factor V [3], 2.1. Strains and culture conditions 
and synaptotagmin [4]. By using Chinese hamster ovary Strain CHO-K1 was obtained from the American Type Culture 
Collection (ATCC CCL 61). CHO-K1, PSA-3, and CDT-1 cells 
(CHO) cell mutants defective in PS biosynthesis, we have were maintained as described [6,11]. For suspension culture, cells 
shown that PS is essential for CHO cell growth and is synthe- were maintained in a spinner vessel containing ES medium (Nissui 
sized by at least two kinds of PS synthases, I and II [5,6], Pharmaceutical Co., Ltd., Tokyo, Japan) supplemented with 10% 
which catalyze an exchange reaction between free L-serine (v/v) fetal bovine serum (ICN Biomedicals, USA), 2 mM L-glutamine, 
100 units of penicillin G per ml, 100 gg of streptomycin sulfate per ml, 
and the base moiety of preexisting phospholipids for PS for- and 2.2 mg of NaHCO3 per ml at 37°C in a 5% CO2 atmosphere at
mation [7,8]. In addition to the serine base-exchange r action, 100% humidity. 
PS synthase I in an extract of CHO cells catalyzes base-ex- 
change reactions of phospholipids with ethanolamine and 2.2. Assay of PS synthase I activity in cellular fractions 
Cells (1MX 10 s cells) were suspended in 10 mM HEPES buffer (pH 
choline, whereas PS synthase II in the extract catalyzes the 7.5) containing 0.25 M sucrose, 1 mM EDTA, 1 mM phenylmethyl- 
ethanolamine base-exchange reaction, but not the choline sulfonyl fluoride (PMSF), 1 ~tg of leupeptin per ml, and 1 gg of 
base-exchange r action, pepstatin A per ml, and disrupted on ice with a W-225R Ultrasonic 
With respect o regulation of PS biosynthesis in mammalian disrupter (Heat System Ultrasonics, USA) equipped with a No. 419 
cells, we found that exogenously added PS is efficiently incor- microtip. Undisrupted cells were removed by centrifugation at750 x g 
for 10 min at 4°C. The supernatant was centrifuged at 100000Xg for 
porated into CHO cells and inhibits endogenous PS biosyn- 1 h at 4°C in a Beckman Ti-70 rotor. The resultant supernatant was 
thesis in the cells [9]. This inhibition is probably not due to a saved as a cytosolic fraction. The pellet was suspended in 10 mM 
HEPES buffer (pH 7.5) containing 1 mM dithiothreitol, 1 mM 
*Corresponding author. Fax: (81) (3) 5285-1157. PMSF, 1 I.tg of leupeptin per ml, and 1 gg of pepstatin A per ml, 
and saved as a membrane fraction. To solubilize membrane proteins, 
Abbreviations. CHO, Chinese hamster ovary; PS, phosphatidylserine; the membrane fraction was suspended on ice in solubilization buffer 
MARCKS, myristoylated alanine-rich C kinase substrate; PMSF, consisting of 7 mM HEPES (pH 7.5), 0.7 mM dithiothreitol, 14% (v/ 
phenylmethylsulfonyl fluoride; PBS, phosphate-buffered saline; v) glycerol, 10 mg of asolectin per ml, and 1% (w/v) sucrose mono- 
MAM, mitochondria-associated m mbranes laurate (Wako Pure Chemical Industries, Osaka, Japan) at a final 
0014-5793/96/$12.00 © 1996 Federation of European Biochemical Societies. All rights reserved. 
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protein concentration of 3 mg per ml. The mixture was then centri- was detected either by a bioimage analyzer (Fujix BAS2000) or by 
fuged at 45 000 rpm (about 81 000 ×g) for 30 min at 4°C in a Beck- immunoblotting with the anti-peptide [447-463] antibody. 
man TLA 100.3 rotor and the resultant supernatant was saved as a To label cellular proteins with [35S]methionine, cells reaching 70- 
fraction of solubilized membrane proteins. About 80% of total pro- 80% confluence in a 100 mm diameter dish were incubated with 120 
teins in the membrane fraction were recovered in the solubilized frac- ~tCi of [35S]methionine (ICN Biomedicals) in 4.5 ml of methionine-free 
tion. Protein in each fraction was measured as described [12]. PS Dulbecco's modified Eagle medium (Gibco-Bethesda Research Lab- 
synthase I activity in each fraction was assayed as the choline base- oratories, USA) supplemented with 580 ~tg of glutamine per ml, 
exchange activity as described [6] by using [methyl-14C]choline chlor- 110 lag of sodium pyruvate per ml, 11% (v/v) newborn calf serum 
ide (American Radiolabeled Chemicals, USA) as a substrate. (Dainippon Pharmaceuticals Co., Ltd., Osaka, Japan) dialyzed 
against PBS, 100 units of penicillin G per ml and 100 lag of strepto- 
2.3. Immunochemical analysis of the pssA product mycin sulfate per ml for 8 h at 37°C. 
A synthetic peptide corresponding to the amino acid residues at 
2.4. Subcellular fractionation positions 4-18 in the pssA protein predicted from the cDNA sequence 
[11] was coupled to SuperCarrier (Pierce, USA) with sulfosuccinimi- Post-nuclear supernatant was prepared from CHO-KI cells from 
dyl-4-(N-maleimidomethyl)cyclohexane-l-carboxylate (Pierce) accord- suspension culture and separated into mitochondria, mitochondria- 
ing to the manufacturer's protocol. Another synthetic peptide corre- associated membranes (MAM), microsome, and cytosol fractions by 
sponding to the amino acid residues at positions 447-463 in the the same procedure as described [17], except hat bovine serum albu- 
predicted pssA protein was coupled to keyhole limpet hemocyanin min was omitted from the buffer used for fractionation. Cytochrome c 
(Sigma Chemical Co., USA)with m-maleimidobenzoyl-N-hydroxysuc- oxidase [18], glucose-6-phosphate phosphatase [19], and CTP:phos- 
cinimide ster (Sigma) as described [13] with slight modifications. The phocholine cytidylyltransferase [20] were assayed as described. 
two peptides were provided by Sumitomo Pharmaceuticals Research 
Center (Osaka, Japan). Peptide [4-18] and peptide [447-463] conju- 
gates (200-300 lag) were emulsified with alum (Pierce) and Freund's 3. Results 
adjuvant (Difco Laboratories, USA), respectively, and injected into 
rabbits every 2 weeks. Antibodies against peptides [4-18] and [447- 3.1. Identification of the pssA protein with antibodies against 
463] were affinity-purified from antisera using peptide-coupled resins 
as described [14] and dialyzed against phosphate-buffered saline (PBS) pssA peptides 
consisting of 137 mM NaC1, 2.7 mM KC1, 1.5 mM KH2PO4, and 6.5 To identify the pssA protein in CHO cells, we prepared 
mM Na2HPO4 (pH 7.4). Resins were prepared by coupling peptides polyclonal antibodies against two pssA peptides correspond- 
[4-18] and [447-463] to SulfoLink Coupling gel (Pierce) and CNBr- ing to the amino acid residues at positions 4-18 and 447-463 
activated Sepharose 4B (Pharmacia-LKB, Sweden), respectively, ac- 
cording to the manufacturer's protocols. Preimmune IgG was purified of the pssA protein deduced from the pssA cDNA sequence 
from preimmune serum using protein A Sepharose CL-4B (Pharma- [11]. By immunoblotting with the anti-peptide [447463] anti- 
cia-LKB) as described [14] and dialyzed against PBS. body, a cross-reacting protein with an apparent molecular 
For immunoblotting, proteins were incubated in SDS sample buffer mass of 42 kDa was found in the membrane fraction of 
consisting of 62.5 mM Tris-HC1 (pH 6.7), 1% (w/v) SDS, 2% (w/v) 2- CHO-K1 cells, but not in their cytosolic fraction (Fig. 1A,B, 
mercaptoethanol, 10% (v/v) glycerol, and 0.025% (w/v) bromophenol 
blue at 37°C for 30 min, separated by electrophoresis in 10% poly- lane 1), whereas neither of the fractions of PSA-3 cells defec- 
acrylamide slab gels containing 0.1% SDS as described [15], and then tive in PS synthase I contained any detectable amount of the 
electroblotted to polyvinylidene difluoride membranes (Biorad, USA) 42-kDa protein (Fig. 1A,B, lane 2). CDT-1 cells carrying the 
as described [16]. The blots were incubated with the anti-peptide [447- pssA cDNA contained a larger amount of the 42-kDa protein 
463] antibody, and then with anti-rabbit IgG linked to horseradish in their membrane fraction than did CHO-K1 ceils, but no peroxidase (Amersham, UK). Cross-reactive proteins were detected by 
enhanced chemiluminescence kit (Amersham) as recommended by the significant amount of the protein was found in their cytosolic 
manufacturer, fraction (Fig. 1A,B, lane 3). Although the 42-kDa protein was 
For immunoprecipitation, membrane fraction was prepared from not detected by immunoblotting with the anti-peptide [4-18] 
35S-labelled (see below) or non-labelled cells, then membrane proteins antibody (data not shown), this antibody was found to pre- 
were solubilized with solubilization buffer as described above (Section 
2.2). A portion of the solubilized fraction was incubated with the anti- cipitate a protein with an apparent molecular mass of 42 kDa 
peptide [4-18] antibody or preimmune IgG in a total volume of 30-50 from solubilized membrane proteins of CDT-1 cells that had 
Ixl on ice for 3 h. The mixture was incubated with 100 lal of 20% (v/v) been metabolically labelled with [35S]methionine (Fig. 2A, 
protein A Sepharose CL-4B suspended in PBS on ice for 1 h, then lane 2). The 42-kDa protein precipitated with the anti-peptide 
briefly centrifuged. The resultant supernatant was saved and the pre- [4-18] antibody cross-reacted with the anti-peptide [447~,63] 
cipitate was washed with 500 ~tl of PBS three times. Proteins in the 
supernatant and precipitate were separated in 10% polyacrylamide antibody (Fig. 2B, lane 2). The corresponding protein was not 
gels containing 0.1% SDS as described above, and the pssA product detected in the precipitates with preimmune IgG (Fig. 2A,B, 
Table 1 
Subcellular distribution of phosphatidylserine synthase I activity in CHO-KI cells 
Enzyme Specific activity in 
PNS Mitochondria MAM Microsomes Cytosol 
PS synthase I 1.43 0.626 9.40 3.53 0 
Cytochrome c oxidase 155 791 109 49.0 2.29 
Glucose-6-phosphate phosphatase 14.5 12.1 33.5 26.5 6.42 
CTP :phosphocholine cytidylyltransferase 122 3.28 7.32 39.4 123 
Subcellular f actions were prepared from CHO-K1 cells and each fraction (50 lag of protein) was assayed for PS synthase I activity in the presence 
of 5 mg of asolectin per ml. The subcellular f actions were also assayed for activities of cytochrome c oxidase (a marker enzyme for mitochondria), 
glucose-6-phosphate phosphatase (a marker enzyme for the MAM and microsomes), and CTP:phosphocholine cytidylyltransferase (a marker 
enzyme for microsomes and cytosol). The units of the enzymes are: PS synthase I, nmol/h/mg protein; cytochrome c oxidase, nmol of cytochrome c 
oxidized/min/mg protein; glucose-6 phosphate phosphatase, nmol of Pi formed/min/mg protein; CTP :phosphocholine cytidylyltransferase, nmol of 
CDP-choline formed/h/mg protein. Specific activities are averages of duplicate assays and varied < 10% between duplicates. PNS is an abbreviation 
for post-nuclear supernatant. 
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Fig. 1. Detection of the pssA protein by immunoblotting. Membrane (A) and cytosolic fractions (B) of CHO-KI (lane 1), PSA-3 (lane 2) and 
CDT-1 (lane 3) cells (50 gg of protein per lane) were separated in a SDS-polyacrylamide g l and subjected to immunoblotting with the anti- 
peptide [447~,63] antibody. The arrow indicates the pssA protein with an apparent molecular mass of 42 kDa. Molecular size markers are la- 
belled on the left. 
lane 1). These results show that the 42-kDa protein was the immunodepletion, the anti-peptide [4-18] antibody inhibited 
pssA gene product, the activity of the solubilized PS synthase I by about 70%, 
whereas an excess of preimmune IgG did not at all (Fig. 4). 
3.2. Elevation of PS synthase I activity in CDT-1 cells 
As in the case of the 42-kDa pssA protein, PS synthase I A .  B°  
activities in CDT-1 and CHO-K1 cells were recovered exclu- 
sively in the membrane fraction, and the specific activity of 
1 2 1 2 
the enzyme in the membrane fraction of CDT-1 cells (kDa)  . . . .  
(77.0_+4.1 nmol/tdmg protein) was approximately 20-fold (kDa)  
higher than that in the membrane fraction of CHO-K1 cells 106 -- 106 -- 
(3.89 _+0.306 nmol/h/mg protein). The membrane and cyto- 80 -- 80 - -  
solic fractions of PSA-3 cells showed no detectable activity 
of the enzyme. These results showed that the transfection of 
the pssA cDNA induced the simultaneous increase in PS 49.5 - -  49.5 - -  
synthase I activity and the amount of the pssA protein. , ,~  .... ~ -~ 
3.3. Immunodepletion a d inhibition of PS synthase I activity 32.5 - -  32.5 --  
by the anti-pssA peptide antibody 27.5 - -  27.5 . 
The membrane fraction of CDT-1 cells was solubilized, 18.5 - -  18.5 --  
then immunoprecipitated with the anti-peptide [4-18] anti- ~ 
body as described in Section 2. The resultant supernatant 
was assayed for the enzyme activity and also analyzed for Fig. 2. Immunoprecipitation f the pssA protein from CDT-1 cells. 
the amount of the pssA protein by immunoblotting with the (A) Membrane35 proteins were prepared from one 100-ram dish cul- 
ture of [ S]methionine-labelled CDT-I cells and solubilized with 
anti-peptide [447463] antibody. As shown in Fig. 3A, PS 250 gl of solubilization buffer. A portion of the solubilized fraction 
synthase I activity in the supernatant was decreased by nearly (45 gl) was immunoprecipitated with 18 gg of the anti-peptide [4- 
50% after immunoprecipitation with the anti-peptide [4-18] 18] antibody (lane 2) or preimmune IgG (lane 1). A half portion of 
antibody, but not with preimmune IgG (Fig. 3A). The pssA the immunoprecipitated proteins was separated in a SDS-polyacryl- 
amide gel. The arrow indicates a protein with an apparent molecu- 
protein in the supernatant was also decreased by nearly 50% lar mass of 42 kDa. Molecular size markers are labelled on the left. 
after immunoprecipitation (Fig. 3B). These results show that (B) Membrane proteins from non-labelled CDT-1 cells were solubil- 
PS synthase I activity in the supernatant was proportional to ized and the solubilized fraction (15 gl) were immunoprecipitated 
the residual amount of the pssA protein. The partial depletion with 15 gg of the anti-peptide [4-18] antibody (lane 2) or preim- 
mune IgG (lane 1). A half portion of the precipitated proteins was 
of the pssA protein was possibly due to incomplete xposure separated in a SDS-polyacrylamide g l and subjected to immuno- 
of epitopes for the anti-peptide [4-18] antibody even after blotting with the anti-peptide [447~,63] antibody. The arrow and 
solubilization with sucrose monolaurate. In addition to the molecular size markers are the same as presented in (A). 
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3.4. Subcellular distribution of PS synthase I activity 
The post-nuclear supernatant prepared from CHO-K1 cells " 
was separated into mitochondria, MAM, microsome, and cy- 100 
tosol fractions. The MAM fraction, which is a microsome-like 
fraction isolated from a crude mitochondrial preparation by 
centrifugation on a Percoll density gradient [17], has been 
shown to exhibit high specific activities of PS synthase and ~ O 
several other lipid-biosynthetic enzymes [17,21]. Fractionation ~ , ,  
into the mitochondria, MAM, microsome, and cytosol frac- ~ ~ 50 
tions was verified by enrichment of marker enzymes into the .,_~- ~. 
corresponding fractions (Table 1). The MAM fraction exhib- ~ o T 
ited much lower specific activities of cytochrome c oxidase ~,9 ,  -2 
and CTP:phosphocholine cytidylyltransferase than the mito- .~- "-" 
chondria and microsome fractions, respectively, and higher ¢~ 
specific activity of glucose-6-phosphate phosphatase than the e~. 
microsome fraction. These characteristics of the MAM frac- o 0 
"= 0 10 20 30 40 
A. Antibodies ([tg) 
"~, Fig. 4. Effect of the anti-peptide [4-18] antibody on PS synthase I 
'~ :[ ~ activity. Membrane proteins from CDT-1 cells were solubilized and 
the solibilized fraction (7.5 gl) was incubated with increasing 
~ _ amounts of the anti-peptide [4-18] antibody (open circles) or preim- 
.~ mune IgG (closed circles) in a total volume of 15 I.tl on ice for 3 h. 
+ k  The mixture was then assayed for PS synthase I activity in the pres- 
ence of 5 mg of asolectin per ml. A control experiment was per- 
formed in the same manner except that incubation with the anti- 
~a O ~ t ~ body was omitted. 
• ,-_ ca 
~ 50 ~_ 
~,~s~ ~ v ~ -O  tion from CHO-K1 cells are consistent with those of the 
.~72~ MAM fraction from rat liver [17]. 
. ~ Using the subcellular f actions, we determined the distribu- 
tion of PS synthase I activity (Table 1). The PS synthase 
g,  0 I , , , , activity was enriched in the MAM and microsome fractions, 
0 10 20 30 40 50 but not in the mitochondria or cytosol fractions. The specific 
B.  Ant ibodies (ktg) activities of the PS synthase in the MAM and microsome 
fractions were respectively 6.6- and 2.5-fold higher than that 
in the post-nuclear supernatant. The recoveries of the PS 
synthase activity in the MAM and microsome fractions ~ 
_~100 ~ from the post-nuclear supernatant were 24% and 50%, respec- 
,~ ~,. ~ tively. 
To compare it with the distribution of PS synthase I activ- 
~- ity, the distribution of the pssA protein in subcellular f actions 5o 
~'~ 50 was determined by immunoblotting with the anti-peptide 
[447~63] antibody (Fig. 5). The pssA protein was enriched 
in the MAM and microsome but in the mito- fractions, not  
o chondria or cytosol fractions. The relative contents of the 
E pssA protein in the MAM and microsome fractions were re- 
spectively 5.8- and 2.1-fold higher than that in the post-nucle- 
i I I i 
0 10 20 30 40 50 ar supernatant. The recoveries of the pssA protein in the 
MAM and microsome fractions from the post-nuclear super- 
Ant ibodies (].tg) natant were 21% and 42%, respectively. These results showed 
Fig. 3. Immunodepletion f PS synthase I activity (A) and the pssA that the level of PS synthase I activity in each subcellular 
protein (B) from solubilized membrane proteins. Membrane proteins fraction was comparable with the amount of the pssA protein. 
from CDT-1 cells were solubilized and the solibilized fraction was 
immunoprecipitated with increasing amounts of the anti-peptide [4- 4. Discussion 
18] antibody (open circles) or preimmune IgG (closed circles). A 
portion of the resultant supernatant (40 ktl) was assayed for PS 
synthase I activity in the presence of 5 mg of asolectin per ml (A). We prepared polyclonal antibodies against two different 
Another portion of the supernatant (15 ~tl) was analyzed by immu- peptides of the predicted pssA product and identified the 
noblotting with the anti-peptide [447~63] antibody (B). A control pssA product as a 42-kDa membrane protein by using the 
experiment was performed in the same manner except hat the anti- 
antibodies. The apparent molecular mass (42 kDa) of the body was omitted. As for (B), the amount of the pssA protein de- 
tected in the immunoblot was estimated ensitometrically using pssA protein in a SDS gel is significantly smaller than the 
NIH Image (ver. 1.57). molecular mass predicted from the cDNA sequence (55.3 
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~ ~,a~O ¢~0~ ~ %,~ ~,~'~ I. metabolism as well as the catalytic mechanism of PS synthase 
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